Market Access
Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.
Don’t Get Left Behind: Evolve With The Changing Healthcare Landscape
February 26 by Pharma IQTechnological innovation, changing demographics, emerging markets, increasing globalization are forcing the industry to re-evaluate the way in which we all do business. Many of healthcare’s challenges...
Ensuring Effective Translations – Translation Memory
February 24 by Andrew LoveAs we complete this series of articles expanding on Ensuring Effective Translations, the next set of tips are to help you plan to have effective document management and how to start building a library...
Serialisation: The South Korean Landscape
February 22 by Chanice HenryFalsified Medicines Directive: Your Time Starts … Now!
February 15 by Chanice HenryThe Falsified Medicines Directive (FMD) has been labeled as a ‘slow and arduous process to: ‘ratify and may be equally difficult to implement’ (1), with some pharma companies being relatively gradual...
On Site at Serialisation & Traceability 2015
February 07 by Chanice HenryPharma IQ talks to some of the attendees at Serialisation & Traceability 2015 to gain their thoughts on the conference
Taking The Supply Chain Pain Out Of Healthcare Mergers And Acquisitions
January 20 by Pharmaceuticals & Biotechnology EditorAccording to a study by the Harvard Business Review, 70-90% of mergers and acquisitions fail.It’s a disconcertingly high rate – particularly when you consider that the cause cited for most failures wa...
Industry Forecast: 2017 Trends
January 13 by Dr Steven BradshawAt the end of last year, Dr Steven Bradshaw examined whether 2016's pharmaceutical predictions came to fruition. Now, he sets his forecasts for the oncoming year.
Global Pharmaceutical Serialisation and Track & Trace Open House 2016
January 06 by Pharmaceuticals & Biotechnology EditorIn the combat against counterfeit drugs, more than 40 markets – those of which including the EU, US, South Korea, Brazil and China, are deploying pharmaceutical track and trace laws. According to indu...
Knowledge Exchange
December 22 by Pharmaceuticals & Biotechnology EditorThe phrase Knowledge Exchange (KE) describing collaborations between industry and the academic community is recognised as having been a key factor in the development of the bio-pharmaceutical se...
Q&A: The Risky Business of Overseas Opportunities
December 22 by Roger HumphreyOpportunity almost always comes with risk—and that's especially true for life sciences companies looking at new markets for new value. While globalization can be a means for driving value, JLL’s Life...
Standardisation within Single Use Systems An Inevitability, But Does It Have To Be Painful?
December 08 by Pharmaceuticals & Biotechnology EditorA dominating focus of today’s single use systems in biomanufacturing is the road towards standardisation between equipment suppliers. The absence of standardisation between single use system sup...